financetom
Business
financetom
/
Business
/
Losses mount for PhonePe, Paytm as they bid to corner payments market share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Losses mount for PhonePe, Paytm as they bid to corner payments market share
Oct 31, 2019 4:56 AM

Digital payments startups in the country have continued to suffer heavy losses. Homegrown firms PhonePe and Paytm saw their losses more than double on a year-on-year as they are locked in a bitter battle for market share against India payment units of Google and Amazon.

Flipkart’s payments arm PhonePe has reported a loss of Rs 1,907 crore for fiscal 2019. It is a 141 percent increase compared to Rs 791 crore losses that the platform reported the year before. The revenue, however, has more than tripled in the same period, rising from 42.8 crore to Rs 184 crore.

It’s a similar story for Paytm. The Softbank and Alibaba-backed payments platform saw its losses spike 165 percent, going from Rs 1,490 crore in March 2018 to Rs 3,959 crore through the same month this year.

PhonePe was sold to Walmart as part of the $16 billion deal that the American giant struck with the Indian e-commerce platform in May 2018. PhonePe is now reported to be in the process of raising $1 billion independent of its parent. Other reports have suggested Walmart is keen to spin off PhonePe into a separate entity valued at $10 billion.

Paytm is run by its parent firm One97 Communications Limited and has raised funding from Japan-based Softbank Group as well as Chinese firm Alibaba Group.

Payment applications in India are locked in a tough fight to corner market share. Apart from PhonePe and Paytm, Amazon Pay, and Google Pay are major players in the country. The firms are pushing investments in the United Payments Interface (UPI), a government-run system to facilitate inter-bank transactions.

They are also spending significant sums in marketing to lure customers, adding to the losses.

First Published:Oct 31, 2019 12:56 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
S&P 500 Hits Another High As Apple Tops $242 For The First Time: Fear Index Remains In 'Greed' Zone
S&P 500 Hits Another High As Apple Tops $242 For The First Time: Fear Index Remains In 'Greed' Zone
Dec 3, 2024
The CNN Money Fear and Greed index remained in the “Greed” zone on Tuesday. U.S. stocks settled mixed on Tuesday, with the S&P 500 hitting another record close during the session. Shares of Apple Inc. ( AAPL ) surged to a new 52-week high on Tuesday. Shares of Zscaler Inc. ( ZS ) fell around 4.7% on Tuesday following first-quarter...
StanChart sets $200 billion new wealth assets target, focuses on Chinese and Indian wealthy
StanChart sets $200 billion new wealth assets target, focuses on Chinese and Indian wealthy
Dec 3, 2024
LONDON/HONG KONG (Reuters) - Standard Chartered ( SCBFF ) will target $200 billion in new assets and double-digit growth in income from its wealth business over the next five years, as part of its wider strategy to shift to higher fee-earning businesses. The Asia-focussed bank wants to expand in serving wealthy Chinese and Indian clients who have assets offshore or...
Stellantis chairman to pick Apple CFO Maestri as carmaker's new CEO - paper
Stellantis chairman to pick Apple CFO Maestri as carmaker's new CEO - paper
Dec 3, 2024
ROME, Dec 4 (Reuters) - Stellantis' ( STLA ) Chairman John Elkann plans to name Luca Maestri, the outgoing CFO of Apple ( AAPL ), as the new CEO of the Italian-French carmaker, newspaper Corriere della Sera reported on Wednesday. Reuters was not immediately able to verify the report. (Writing by Gavin Jones, editing by Cristina Carlevaro) ...
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln
Dec 3, 2024
Dec 4 (Reuters) - U.S. drugmaker Novavax ( NVAX ) said on Wednesday that it has signed an agreement to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk for $200 million. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved